Want to see JP:2931 full AI Analyst Report?
2931 Stock Chart & Stats
¥407.00
-¥7.00(-1.67%)
At close: 4:00 PM EST
¥407.00
-¥7.00(-1.67%)
Day’s Range― - ―
52-Week Range¥318.00 - ¥468.00
Previous CloseN/A
Volume629.20K
Average Volume (3M)723.50K
Market Cap
¥49.10B
Enterprise Value¥51.31K
Total Cash (Recent Filing)¥17.17B
Total Debt (Recent Filing)¥23.06B
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.57%
Share Statistics
EPS (TTM)-1.28
Shares Outstanding139,521,760
10 Day Avg. Volume609,690
30 Day Avg. Volume723,496
Financial Highlights & Ratios
PEG Ratio-3.10
Price to Book (P/B)1.76
Price to Sales (P/S)1.08
P/FCF Ratio10.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.8
Revenue Forecast (FY)¥51.90B
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Operating TurnaroundRevenue expanded substantially (roughly ¥13.3B in 2020 to ~¥50.4B in 2025) while operating profit turned positive in 2024 and improved further in 2025. Sustained top-line scale and an operating-profit turnaround indicate durable demand, improved operating leverage, and greater ability to self-fund growth and absorb shocks over the medium term.
Very Strong, Stable Gross MarginsConsistently high gross margins (high‑60s to low‑70s) point to structural unit economics driven by proprietary cultivation and processing capabilities. Such margins create long-term pricing flexibility, room to invest in R&D and marketing, and a margin buffer that supports sustainable operating profitability as revenue scales.
Improved Cash Generation And Free Cash FlowOperating cash flow and free cash flow strengthened materially in 2024–2025, with FCF near ¥5.0B in 2025 after years of weak cash generation. Improved FCF signals better cash discipline, lowers dependence on external financing, and provides a durable funding source for capex, product development, and strategic initiatives over coming quarters.
Bears Say
Net Losses And Negative ROEDespite an operating turnaround, the company still reports net losses and negative return on equity across the period. Persistent bottom‑line deficits constrain retained earnings and shareholder returns, may necessitate future capital raises if not resolved, and limit the company's long‑term financial resilience.
Rising Absolute Debt Levels Since 2023Although leverage ratios improved, nominal debt has increased since 2023, raising fixed interest and repayment obligations. Higher absolute debt combined with ongoing net losses elevates refinancing and interest‑service risk, reducing strategic flexibility and amplifying downside if cash generation falters.
Modest Cash Conversion And Historical VolatilityOperating cash flow relative to revenue remains modest (~0.37 in 2025) and earlier years showed volatile or negative OCF. Low conversion and historical swings make cash flows less predictable, complicating planning for capex, dividends, or deleveraging and increasing sensitivity to working‑capital or demand shifts.
euglena Co., Ltd. News
2931 FAQ
What was euglena Co., Ltd.’s price range in the past 12 months?
euglena Co., Ltd. lowest stock price was ¥318.00 and its highest was ¥468.00 in the past 12 months.
What is euglena Co., Ltd.’s market cap?
euglena Co., Ltd.’s market cap is ¥49.10B.
When is euglena Co., Ltd.’s upcoming earnings report date?
euglena Co., Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 60 days.
How were euglena Co., Ltd.’s earnings last quarter?
euglena Co., Ltd. released its earnings results on Aug 07, 2026. The company reported ¥0.76 earnings per share for the quarter.
Is euglena Co., Ltd. overvalued?
According to Wall Street analysts euglena Co., Ltd.’s price is currently Overvalued.
Does euglena Co., Ltd. pay dividends?
euglena Co., Ltd. pays a Notavailable dividend of ¥2 which represents an annual dividend yield of 0.57%. See more information on euglena Co., Ltd. dividends here
What is euglena Co., Ltd.’s EPS estimate?
euglena Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does euglena Co., Ltd. have?
euglena Co., Ltd. has 139,521,760 shares outstanding.
What happened to euglena Co., Ltd.’s price movement after its last earnings report?
euglena Co., Ltd. reported an EPS of ¥0.76 in its last earnings report. Following the earnings report the stock price went up 1.493%.
Which hedge fund is a major shareholder of euglena Co., Ltd.?
Currently, no hedge funds are holding shares in JP:2931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
euglena Co., Ltd.
Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
Technical Analysis
Kao
―
Kobayashi Pharmaceutical Co
―
Kose
―
Rohto Pharmaceutical Co
―
Shiseido Company,Limited
―